Table 1.
Demographic characteristics, clinical information, and lab data of patients (N = 67). No significant differences between responder and poor responder in patient's characteristics were observed at all times by 5 µM ADP (P > 0.05).
| Total |
ADP 5 µM
|
|||||||
|---|---|---|---|---|---|---|---|---|
|
2 h
|
24 h
|
30 days
|
||||||
| P f | R g | P | R | P | R | |||
| Age (year), mean ± SD | 57.78 ± 10.80 | 57.03 ± 10.29 | 58.70 ± 11.38 | 56.47 ± 9.50 | 58.67 ± 11.57 | 56.23 ± 9.64 | 58.88 ± 11.56 | |
| Sez | 47 (70.1) | 23 (50.0) | 23 (50.0) | 15 (33.3) | 30 (66.7) | 16 (35.6) | 29 (64.4) | 29 (64.4) |
| 20 (29.9) | 9 (45.0) | 11 (55.0) | 4 (21.1) | 15 (78.9) | 5 (26.3) | 14 (73.7) | 14 (73.7) | |
| Smoking, NO (%) | 27 (40.3) | 13 (48.1) | 14 (51.9) | 8 (29.6) | 19 (70.4) | 9 (33.3) | 18 (66.7) | |
| Diabetes Mellitus, NO (%) | 14 (20.9) | 7 (50.0) | 7 (50.0) | 5 (35.7) | 9 (64.3) | 5 (35.7) | 9 (64.3) | |
| HTNa (BP ≥140/90 mmHg), NO (%) | 32 (47) | 13 (41.9) | 18 (58.1) | 5 (16.1) | 26 (83.6) | 9 (29.0) | 22 (71.0) | |
| Hyperlipidemia (LDL-C≥100 mg/dL), NO (%) | 49 (73.1) | 22 (45.8) | 26 (54.2) | 14 (29.8) | 33 (70.2) | 16 (34.0) | 31 (66.0) | |
| BMIb (kg/m2), mean ± SD | 26.25 ± 4.02 | 27.40 ± 4.23 | 25.09 ± 3.54 | 27.21 ± 4.02 | 25.89 ± 4.03 | 27.56 ± 4.71 | 25.68 ± 3.62 | |
| LVEFc<45%, NO (%) | 6 (9.0) | 3 (50.0) | 3 (50.0) | 2 (33.3) | 4 (66.7) | 2 (33.3) | 4 (66.7) | |
| WBCd (× 1000/µL), mean ± SD | 7.28 ± 2.16 | 6.95 ± 1.63 | 7.64 ± 2.56 | 7.75 ± 2.87 | 7.04 ± 1.81 | 7.14 ± 1.92 | 7.31 ± 2.32 | |
| PLTe (× 1000/µL), mean ± SD | 229.9 ± 67.48 | 219.44 ± 59.71 | 241.82 ± 73.24 | 226.37 ± 65.81 | 226.37 ± 65.81 | 225.19 ± 58.97 | 234.07 ± 73.21 | |
A: hypertension; b: body mass index; c: left ventricular ejection fraction; d: white blood cell; e: platelet; f: poor responder; g: responder.